- Home
- AYTU vs IMCC Comparison
AYTU vs IMCC Comparison
Compare AYTU & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- IMCC
- Stock Information
- Founded
- AYTU N/A
- IMCC 1980
- Country
- AYTU United States
- IMCC Israel
- Employees
- AYTU N/A
- IMCC N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- AYTU Health Care
- IMCC Health Care
- Exchange
- AYTU Nasdaq
- IMCC Nasdaq
- Market Cap
- AYTU 9.8M
- IMCC 8.8M
- IPO Year
- AYTU N/A
- IMCC N/A
- Fundamental
- Price
- AYTU $1.38
- IMCC $2.08
- Analyst Decision
- AYTU
- IMCC
- Analyst Count
- AYTU 0
- IMCC 0
- Target Price
- AYTU N/A
- IMCC N/A
- AVG Volume (30 Days)
- AYTU 37.2K
- IMCC 245.8K
- Earning Date
- AYTU 02-12-2025
- IMCC 11-14-2024
- Dividend Yield
- AYTU N/A
- IMCC N/A
- EPS Growth
- AYTU N/A
- IMCC N/A
- EPS
- AYTU N/A
- IMCC N/A
- Revenue
- AYTU $79,759,000.00
- IMCC $38,042,859.00
- Revenue This Year
- AYTU N/A
- IMCC $22.59
- Revenue Next Year
- AYTU N/A
- IMCC $20.53
- P/E Ratio
- AYTU N/A
- IMCC N/A
- Revenue Growth
- AYTU N/A
- IMCC N/A
- 52 Week Low
- AYTU $1.30
- IMCC $1.13
- 52 Week High
- AYTU $3.45
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- AYTU 33.90
- IMCC 39.85
- Support Level
- AYTU $1.30
- IMCC $1.61
- Resistance Level
- AYTU $1.47
- IMCC $2.65
- Average True Range (ATR)
- AYTU 0.12
- IMCC 0.36
- MACD
- AYTU -0.01
- IMCC -0.11
- Stochastic Oscillator
- AYTU 17.78
- IMCC 26.40
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.